Association between serum uric acid and atrial fibrillation: A systematic review and meta-analysis

Heart Rhythm

Volumn 11, Issue 7, 2014, Pages 1102-1108

  Tamariz, Leonardo ^a,b   Hernandez, Fernando ^a,b   Bush, Aaron ^a   Palacio, Ana ^a,b   Hare, Joshua M ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Atrial fibrillation; Epidemiology; Meta analysis; Oxidative stress; Uric acid

Indexed keywords

URIC ACID; BIOLOGICAL MARKER;

ARTICLE; DISEASE MARKER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL; BLOOD; META ANALYSIS; OXIDATIVE STRESS; RISK FACTOR;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; HUMANS; OXIDATIVE STRESS; RISK FACTORS; URIC ACID;

EID: 84903207596     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.04.003     Document Type: Article

References (38)

1. W.B. Kannel, P.A. Wolf, E.J. Benjamin, and D. Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 1998 2N 9N
2. L. Tamariz, A. Harzand, A. Palacio, S. Verma, J. Jones, and J. Hare Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis Congest Heart Fail 17 2011 25 30
3. S.Y. Kim, J.P. Guevara, K.M. Kim, H.K. Choi, D.F. Heitjan, and D.A. Albert Hyperuricemia and coronary heart disease: a systematic review and meta-analysis Arthritis Care Res (Hoboken) 62 2010 170 180
4. J.E. Tisdale, S. Borzak, H.N. Sabbah, H. Shimoyama, and S. Goldstein Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure J Card Fail 12 2006 747 751
5. J.Y. Youn, J. Zhang, Y. Zhang, H. Chen, D. Liu, P. Ping, J.N. Weiss, and H. Cai Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase J Mol Cell Cardiol 62 2013 72 79
6. K. Friedrichs, A. Klinke, and S. Baldus Inflammatory pathways underlying atrial fibrillation Trends Mol Med 17 2011 556 563
7. C.E. Berry, and J.M. Hare Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications J Physiol 555 2004 589 606
8. F. Ghaemi-Oskouie, and Y. Shi The role of uric acid as an endogenous danger signal in immunity and inflammation Curr Rheumatol Rep 13 2011 160 166
9. Y. Shi, J.E. Evans, and K.L. Rock Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 2003 516 521
10. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, and J.P. Vandenbroucke STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Ann Intern Med 147 2007 573 577
11. Q.Y. Zhao, S.B. Yu, H. Huang, H.Y. Cui, M. Qin, T. Huang, and C.X. Huang Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure Chin Med J (Engl) 125 2012 1708 1712
12. K.P. Letsas, P. Korantzopoulos, G.S. Filippatos, C.C. Mihas, V. Markou, G. Gavrielatos, M. Efremidis, A. Sideris, and F. Kardaras Uric acid elevation in atrial fibrillation Hellenic J Cardiol 51 2010 209 213
13. T. Liu, X. Zhang, P. Korantzopoulos, S. Wang, and G. Li Uric acid levels and atrial fibrillation in hypertensive patients Intern Med 50 2011 799 803
14. Y. Liu, H. Liu, L. Dong, J. Chen, and J. Guo Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the People's Hospital of Peking University Acta Cardiol 65 2010 221 224
15. Y.F. Hu, S.A. Chen, and H.I. Yeh Metabolic syndrome does not impose greater atrial fibrillation risk in elderly hypertensive patients Acta Cardiol 65 2010 653 659
16. G. Tekin, Y.K. Tekin, A.R. Erbay, H. Turhan, and E. Yetkin Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure Angiology 64 2013 300 303
17. S.M. Kim, J.H. Lee, J.R. Kim, D.G. Shin, S.H. Lee, and K.H. Cho Female patients with atrial fibrillation have increased oxidized and glycated lipoprotein properties and lower apolipoprotein A-I expression in HDL Int J Mol Med 27 2011 841 849
18. L. Tamariz, S. Agarwal, E.Z. Soliman, A.M. Chamberlain, R. Prineas, A.R. Folsom, M. Ambrose, and A. Alonso Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study) Am J Cardiol 108 2011 1272 1276
19. T.F. Chao, C.L. Hung, S.J. Chen, K.L. Wang, T.J. Chen, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, and S.A. Chen The association between hyperuricemia, left atrial size and new-onset atrial fibrillation Int J Cardiol 168 2013 4027 4032
20. F. Valbusa, L. Bertolini, S. Bonapace, L. Zenari, G. Zoppini, G. Arcaro, C.D. Byrne, and G. Targher Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus Am J Cardiol 112 2013 499 504
21. M. Rienstra, D.D. McManus, and E.J. Benjamin Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making? Circulation 125 2012 e941 e946
22. K.K. Patton, P.T. Ellinor, S.R. Heckbert, R.H. Christenson, C. DeFilippi, J.S. Gottdiener, and R.A. Kronmal N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study Circulation 120 2009 1768 1774
23. R.B. Schnabel, M.G. Larson, J.F. Yamamoto, S. Kathiresan, J. Rong, D. Levy, J.F. Keaney Jr, T.J. Wang, R.S. Vasan, and E.J. Benjamin Relation of multiple inflammatory biomarkers to incident atrial fibrillation Am J Cardiol 104 2009 92 96
24. R.B. Schnabel, M.G. Larson, and J.F. Yamamoto et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community Circulation 121 2010 200 207
25. R.B. Schnabel, L.M. Sullivan, and D. Levy et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study Lancet 373 2009 739 745
26. A.M. Chamberlain, S.K. Agarwal, A.R. Folsom, E.Z. Soliman, L.E. Chambless, R. Crow, M. Ambrose, and A. Alonso A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study) Am J Cardiol 107 2011 85 91
27. A. Alonso, B.P. Krijthe, and T. Aspelund et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium J Am Heart Assoc 2 2013 e000102
28. R.B. Schnabel, T. Aspelund, and G. Li et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans Arch Intern Med 170 2010 1909 1917
29. D.I. Feig, B. Soletsky, and R.J. Johnson Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial JAMA 300 2008 924 932
30. J.M. Hare, B. Mangal, J. Brown, C. Fisher Jr, R. Freudenberger, W.S. Colucci, D.L. Mann, P. Liu, M.M. Givertz, and R.P. Schwarz OPT-CHF Investigators. Impact of oxypurinol in patients with symptomatic heart failure: results of the OPT-CHF study J Am Coll Cardiol 51 2008 2301 2309
31. S. Yagi, M. Akaike, K. Aihara, K. Ishikawa, T. Iwase, Y. Ikeda, T. Soeki, S. Yoshida, Y. Sumitomo-Ueda, T. Matsumoto, and M. Sata Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury Hypertension 55 2010 918 923
32. K. Tziomalos, and J.M. Hare Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance Front Biosci (Landmark Ed) 14 2009 237 262
33. T.P. Cappola, D.A. Kass, G.S. Nelson, R.D. Berger, G.O. Rosas, Z.A. Kobeissi, E. Marban, and J.M. Hare Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy Circulation 104 2001 2407 2411
34. P. Korantzopoulos, K.P. Letsas, and T. Liu Xanthine oxidase and uric acid in atrial fibrillation Front Physiol 3 2012 150
35. P. Korantzopoulos, T.M. Kolettis, D. Galaris, and J.A. Goudevenos The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation Int J Cardiol 115 2007 135 143
36. J. Kanellis, S. Watanabe, J.H. Li, D.H. Kang, P. Li, T. Nakagawa, A. Wamsley, D. Sheikh-Hamad, H.Y. Lan, L. Feng, and R.J. Johnson Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 Hypertension 41 2003 1287 1293
37. D.H. Kang, L. Han, and X. Ouyang et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter Am J Nephrol 25 2005 425 433
38. W. Baldwin, S. McRae, G. Marek, D. Wymer, V. Pannu, C. Baylis, R.J. Johnson, and Y.Y. Sautin Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome Diabetes 60 2011 1258 1269